CHRU de Brest
Brest, 29609, France
NCT Number: NCT03657992
Following the implementation of SPECT V/Q imaging for PE diagnosis, the investigators previously conducted an observational study over the period 2011-2013 that showed the safety of a diagnostic management based on SPECT V/Q to rule out PE. However, PE prevalence was high (28%), which may seem a bit high as compared with other recent studies. The hypothesis was that the use of SPECT V/Q may be responsible for an overdiagnosis of PE, especially at the implementation phase of the test. The aim of this study was to perform a time trend analysis of the evolution over the years of PE diagnosis with SPECT V/Q.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Brest, 29609, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: April 2011 to December 2016
positive, negative, or non-conclusive
Time frame: up to 3 Months following the date of the SPECT V/Q scan
University Hospital, Brest
Other
Time Trend Analysis of Pulmonary Embolism Diagnosis With SPECT V/Q: a Single Institution Observational Study From 2011 to 2016
Acronym: TOMOBS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06015529
Cardiovascular Diseases, Embolism
Brussels, Belgium
View Trial DetailsNCT04014972
Acute Aortic Syndrome, Aneurysm
View Trial DetailsNCT07689136
Cardiovascular Diseases, Deep Vein Thrombosis
Tunis, Tunisia
View Trial DetailsNCT06183944
Cardiovascular Diseases, Embolism
Toulon, France
View Trial Details